Akash Chavan
60 posts


🚨BREAKING: FDA grants accelerated approval to Wegovy (semaglutide 2.4 mg injection) for treating adults with non‑cirrhotic metabolic dysfunction‑associated steatohepatitis (MASH) with moderate to advanced liver fibrosis - - - A Fourth Indication for Wegovy Wegovy’s FDA-approved indications now include: 1. Weight management in adults (2021) 2. Pediatric obesity (extended to ≥12 years old in 2022) 3. Cardiovascular risk reduction (added in 2024) 4. MASH treatment with moderate–advanced fibrosis (2025) 🔗prnewswire.com/news-releases/…





















So proud of @cwruim PGY2 IM resident Shaina Ailawadi for winning the best poster award today at the annual @OHgastrosociety meeting on a project I mentored her on. Keep up the great work Shaina! @CWRU_GI @UH_RE_Institute


















